Functional Incremental Stepping in Place Test (F-IST) Validation
Launched by UNIVERSITY OF KENTUCKY · Feb 24, 2025
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new test called the Functional Incremental Stepping in Place Test (F-IST). The goal is to see how well this test works compared to the standard method used to measure exercise capacity, known as cardiopulmonary exercise testing (CPET). The researchers want to find out if the F-IST is a good way to assess physical function in patients, especially those in intensive care units (ICUs). They will also check if the test gives consistent results over time.
To participate in the trial, you need to be between the ages of 65 and 74 and be able to walk, either with or without a walking aid like a cane or walker. However, there are some health conditions that might prevent you from joining, such as serious heart problems, certain infections, or severe high blood pressure. If eligible, participants can expect to take part in the F-IST and may also undergo other assessments related to their physical health. This study is currently looking for volunteers, and it aims to improve how we evaluate patients' physical abilities in critical care settings.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -Currently able to walk with or without a walking aid, such as a cane or walker or rollator
- Exclusion Criteria:
- • Pregnancy
- • specifically related to cardiopulmonary testing
- • A recent significant change in resting ECG
- • Unstable angina
- • Uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise
- • Symptomatic severe aortic stenosis
- • Uncontrolled symptomatic heart failure
- • Acute pulmonary embolus or pulmonary infarction
- • Acute myocarditis or pericarditis
- • Suspected or known dissecting aneurysm
- • Acute systemic infection accompanied by fever, body aches, or swollen lymph glands
- • Left Main Coronary Stenosis
- • Moderate stenotic valvular heart disease
- • Electrolyte abnormalities
- • Severe arterial hypertension (\>200 systolic, \>110 diastolic) at rest
- • Tachydysrhythmia or bradydysrhythmia
- • Hypertrophic cardiomyopathy and other forms of outflow tract obstruction
- • Neuromuscular, musculoskeletal, or rheumatic disorders that are exacerbated by exercise
- • High degree AV block
- • Ventricular aneurysm
- • Uncontrolled metabolic disease (diabetes, thyrotoxicosis, or myxedema)
- • Chronic infectious disease (hepatitis, AIDS, mono)
- • Mental or physical impairment leading to inability to exercise adequately
About University Of Kentucky
The University of Kentucky is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing medical challenges. The institution is committed to ethical research practices and strives to enhance community health by translating scientific discoveries into effective treatments and interventions. Through its Clinical Trials Office, the University of Kentucky fosters a supportive environment for researchers and participants alike, ensuring a comprehensive approach to clinical research that meets the highest standards of excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Boca Raton, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported